Here are three notes:
1. The Algovita SCS system is a CE marked and FDA approved for treating trunk and limb chronic pain.
2. Nuvectra hopes to have MRI-conditional approval by the end of 2017, following the 180-day review process.
3. The Algovita SCS system is Nuvectra’s first commercial offering.
More articles on devices:
Jon Stryker is Michigan’s top philanthropist, donating $336M in the state since 2000
Medtronic’s Luann Pendy on diversity in the medical device field: 7 key thoughts
K2M reveals SAHARA AL Expandable Stabilization System: 5 takeaways
Nuvectra seeks FDA MRI-conditional approval for Algovita SCS system — 3 notes (devices, fp)
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
